Article info
Coronary artery disease
Original research
Aspirin versus P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation
- Correspondence to Professor Junya Ako, Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Kanagawa 252-0374, Japan; jako{at}kitasato-u.ac.jp
Citation
Aspirin versus P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation
Publication history
- Received March 8, 2021
- Accepted June 9, 2021
- First published July 14, 2021.
Online issue publication
October 11, 2021
Article Versions
- Previous version (14 July 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.